FOLD Related
-
Amicus Therapeutics to Present at UBS Global Healthcare Conference
-
Form 10-Q AMICUS THERAPEUTICS INC For: Mar 31
-
Form 8-K AMICUS THERAPEUTICS INC For: May 09
-
Amicus Therapeutics Announces First Quarter 2013 Financial Results and Corporate Updates
-
Amicus Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
-
Form 8-K AMICUS THERAPEUTICS INC For: Apr 18
-
Amicus Therapeutics to Present at 12th Annual Needham Healthcare Conference
-
Stocks Crossing 50-Day SMA 03/18: (AMD) (KORS) (FOLD) Above; (NXPI) (WFR) (MHR) Below
-
Amicus Therapeutics, Inc. (FOLD) Posts Q4 Loss of 20c/Share
-
Stocks Crossing 50-Day SMA 02/15: (GPS) (MNST) (AMRN) Above; (WMT) (TGT) (FOLD) Below
-
Unusual 11 Mid-Day Movers 02/15: (URRE) (QLIK) (SAAS) Higher; (LOGM) (FOLD) (EHTH) Lower
-
Amicus Therapeutics (FOLD) Ticks Lower on Following Study Results
-
Amicus (FOLD) Sees Net Cash Spend Up to $58M in FY13; Provides Update
-
Unusual 11 Mid-Day Movers 01/04: (DRYS) (SCTY) (HNR) Higher; (ARAY) (SIMG) (FINL) Lower
-
StreetInsider.com Pre-Open Movers 01/04: (FOLD) (HNR) (KKD) Higher; (ARAY) (FINL) (LULU) Lower (more...)
-
Amicus Therapeutics (FOLD) Reports Positive Data from All Cohorts in ERT Co-Admin Study for Pompe Disease
-
Unusual 11 Mid-Day Movers 01/03: (SPWR) (LDK) (BGMD) Higher; (LPH) (ALLT) (MLNX) Lower
-
Janney Montgomery Scott Starts Amicus Therapeutics (FOLD) at Buy
-
Notable 52-Week Highs and Lows of the Day 12/26: (BAC) (RDN) (GM) High; (ZUMZ) (PBI) (FOLD) Low
-
Wedbush Downgrades Amicus Therapeutics (FOLD) to Underperform, Sees Another 50% Slide
-
StreetInsider.com Pre-Open Movers 12/21: (ASCA) (RHT) (NKE) Higher; (HEB) (ECTE) (RIMM) Lower (more...)
-
Unusual 11 Mid-Day Movers 12/20: (ROMA) (NYX) (ELOQ) Higher; (FOLD) (MDRX) (UNXL) Lower
-
Leerink Swann Cuts PT on Amicus Therapeutics (FOLD), But Remains Overall Bullilsh
-
StreetInsider.com Pre-Open Movers 12/20: (NYX) (RAD) (ILMN) Higher; (FOLD) (MDRX) (SYMM) Lower (more...)
-
StreetInsider.com After-Hours Movers 12/19: (SD) (JBL) (BKR) Higher; (FOLD) (ACN) (BBBY) Lower (more...)
-
Amicus (FOLD) Slammed Following Study 011 Update
-
Amicus Therapeutics (FOLD) to resume trading at 4:30PM ET
-
Amicus Therapeutics (FOLD), Glaxo (GSK) Report Study 011 Did Not Achieve Primary Endpoint
-
Amicus Therapeutics (FOLD) halted, news pending
-
Amicus (FOLD) Files $145M Mixed Shelf
-
Amicus Therapeutics, Inc. (FOLD) Misses Q3 EPS by 7c
-
Amicus Therapeutics (FOLD) Updated Phase 2 on HCI for Fabry Disease
-
Notable Analyst Rating Changes 11/01: (CRUS) (JOY) (RVBD) Upgraded; (NFLX) (ZUMZ) (RDC) Downgraded
-
Capstone Investments Starts Amicus Therapeutics (FOLD) at Buy
-
Amicus Therapeutics (FOLD) Files 2.95M Common Shelf for Shareholder
-
Amicus (FOLD) Hits Study 012 Enrollment Target (GSK)
-
Amicus Therapeutics (FOLD) Announces Positive Pompe Program Updates
-
Amicus Therapeutics (FOLD) Updates on Study 011 in Fabry Disease
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Migalastat Ph3 Data Preview
-
Morning Movers 07/18: (SUPN) (GALE) (AIR) (APH) Higher; (ROVI) (WHX) (HHS) Lower
-
Pre-Open Winners 7/18: (SOMX) (VVUS) (AIRM) Higher
-
Amicus Therapeutics (FOLD) and Glaxo (GSK) Expand Collaboration for Fabry Disease
-
ThinkEquity Starts Amicus Therapeutics (FOLD) at Buy
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Catalysts in Q2 & Q3
-
Amicus Therapeutics (FOLD) Reports Encouraging Data from AT2220 Phase 2
-
Amicus Therapeutics (FOLD) Was Added to Nasdaq Biotech Index
-
NASDAQ OMX (NDAQ) Adds 10 Stocks to NASDAQ Biotechnology Index (NBI)
-
Canaccord Genuity Reiterates a 'Buy' on Amicus Therapeutics (FOLD); Encouraged on Upcoming Data
-
Amicus Therapeutics, Inc. (FOLD) Tops Q1 EPS by 1c; Guides In-line
-
JPMorgan Upgrades Amicus Therapeutics (FOLD) to Overweight
Back to FOLD Stock Lookup
